Health / Medical Topics

    Therapeutic angiotensin-(1-7)

    Pronunciation

    Definition 1

    A substance being studied in the treatment of several types of cancer. Therapeutic angiotensin-(1-7) is a hormone that is made in the laboratory, and helps control blood pressure. It may stop the growth of some types of cancer cells and may stop the growth of blood vessels needed by tumors to grow. It is a type of antiproliferative agent. (NCI Dictionary)

    Definition 2

    A synthetic heptapeptide identical to endogenous angiotensin-(1-7) with vasodilator and antiproliferative activities. Therapeutic angiotensin 1-7 may inhibit cyclooxygenase 2 (COX-2) and the production of proinflammatory prostaglandins and may activate the angiotensin-(1-7) receptor Mas, resulting in diminished tumor cell proliferation. Activation of the angiotensin-(1-7) receptor Mas, a G-protein coupled, seven transmembrane protein, may down-regulate the phosphorylation and activation of Erk1 and Erk2 in the Erk1/Erk2 MAPK signaling pathway. In the renin-angiotensin system, the vasodilating activity of angiotensin- (1-7), hydrolysed from angiotensin II by the type I transmembrane metallopeptidase and carboxypeptidase angiotensin converting enzyme 2 (ACE2) in vivo, counteracts the vasoconstricting activity of angiotensin II. (NCI Thesaurus)




    YOU MAY ALSO LIKE

    A potent androgenic prohormone that is a direct precursor of testosterone and used as a supplement to increase plasma testosterone levels and…
    A therapeutic anabolic steroid hormone identical to endogenous dihydrotestosterone. Androstanolone binds to and activates specific nuclear receptors. This agent may…
    A class of sex hormones associated with the development and maintenance of the secondary male sex characteristics, sperm induction, and sexual…
    A population of lymphocytes therapeutically administered to a recipient individual who is genetically distinct from a donor of the same species. …
    A population of cytotoxic T-lymphocytes (CTLs) that are therapeutically administered to a recipient individual who is genetically distinct from a donor of…
    Funds allocated for basic research of the development of physical or chemical agents that may improve the health of a patient by…

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact